DrugPatentWatch Database Preview
Drugs in Development Information for Mafosfamide
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Mafosfamide?
Mafosfamide is an investigational drug.
There have been 5 clinical trials for Mafosfamide.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 1990.
The most common disease conditions in clinical trials are Meningeal Neoplasms, Nervous System Neoplasms, and Central Nervous System Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Texas Children's Hospital, and Baylor College of Medicine.
Summary for Mafosfamide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (1990-06-01) |
| Vendors | 16 |
Recent Clinical Trials for Mafosfamide
| Title | Sponsor | Phase |
|---|---|---|
| Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia | National Cancer Institute (NCI) | N/A |
| Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute Leukemia | Sidney Kimmel Comprehensive Cancer Center | N/A |
| Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors | National Cancer Institute (NCI) | Phase 1 |
Clinical Trial Summary for Mafosfamide
Top disease conditions for Mafosfamide
Top clinical trial sponsors for Mafosfamide
US Patents for Mafosfamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
